Vyant Bio Investor Relations Material
Latest events
Q3 2022
Vyant Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vyant Bio Inc
Access all reports
Vyant Bio, Inc. operates as a biotechnology drug discovery company. The company discovers, develops, and commercializes antimicrobial drugs to treat acute respiratory tract infections, including pneumonia and influenza.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
VYNT
Country
🇺🇸 United States